Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021
Jun Ran, Ping Zhou, Jinxi Wang et al. · Biomarker Research · 2025
Full textCC BY
Cardiology and Cardiovascular Medicine
Filters2 filters applied
Status
Year
Readable here
Study type
Licence
168 papers5 CorrectedQuestions on this topic
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Saixian Shi, Ye Chen, Zhijian Luo et al. · Cell Communication and Signaling · 2023 · Review
Full textCC BY
Association of the American Heart Association’s new “Life’s Essential 8” with all-cause and cardiovascular disease-specific mortality: prospective cohort study
Jiahong Sun, Yanzhi Li, Min Zhao et al. · BMC Medicine · 2023
Full textCC BY
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
Jawad H Butt, Mark C Petrie, Pardeep S Jhund et al. · European Heart Journal · 2023
Full textCC BY
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management
Gloria Santangelo, Francesca Bursi, Andrea Faggiano et al. · Journal of Clinical Medicine · 2023 · Review
Full textCC BY
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Jin-Ling Huo, Qi Feng, Shaokang Pan et al. · Cell Death Discovery · 2023 · Review
Full textCC BY
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction
Kazuo Miyazawa, Kaoru Ito, Masamichi Ito et al. · Nature Genetics · 2023 · Meta-analysis
Full textCC BY
Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis
Grace O Dibben, James Faulkner, Neil Oldridge et al. · European Heart Journal · 2023 · Meta-analysis
Full textCC BY
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial
Isla S Mackenzie, Amy Rogers, Neil R Poulter et al. · The Lancet · 2022 · Randomised trial
Full textCC BY
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu, Kam Tong Leung, Ellen Ngar-Yun Poon · International Journal of Molecular Sciences · 2022 · Review
Full textCC BY
Heart Rate Variability and Pain: A Systematic Review
Giuseppe Forte, Giovanna Troisi, Mariella Pazzaglia et al. · Brain Sciences · 2022 · Review
Full textCC BY
Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis
Toshiyuki Ko, Seitaro Nomura, Shintaro Yamada et al. · Nature Communications · 2022
Full textCC BY
Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy
Jingui Hu, Tao Liu, Fei Fu et al. · Journal of Translational Medicine · 2022
Full textCC BY
Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida et al. · International Journal of Molecular Sciences · 2022 · Review
Full textCC BY
Impacts of the COVID-19 Pandemic on Cardiac Rehabilitation Delivery around the World
Gabriela Lima de Melo Ghisi, Zhiming Xu, Xia Liu et al. · Global Heart · 2021
Full textCC BY
Corrected Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh et al. · The Lancet · 2021 · Meta-analysis
Full textCC BY
Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction
Irina Kologrivova, Marina Shtatolkina, Tatiana Suslova et al. · Frontiers in Immunology · 2021 · Review
Full textCC BY
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
Milton Packer, Javed Butler, Faiez Zannad et al. · Circulation · 2021 · Randomised trial
Full textCC BY
Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study
Shujie Wang, Juan Shi, Ying Peng et al. · Cardiovascular Diabetology · 2021
Full textCC BY
The mechanosensitive Piezo1 channel mediates heart mechano-chemo transduction
Fan Jiang, Kunlun Yin, Kun Wu et al. · Nature Communications · 2021
Full textCC BY